Among several anti-diabetic medications, a systemic analysis reveals that GLP1-RAs and dual GLP-1/Gastric inhibitory polypeptide (GIP) agonists such as tirzepatide are most effective at causing weight loss in patients with type 2 diabetes (63). The gene discussed is GIP; the disease is type 2 diabetes mellitus.